Ovid Therapeutics Inc. SEC filings OVID
Ovid Therapeutics Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 18, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Aug 24, 2026 | — |
| 144 | Notice of proposed sale | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K | Current report | Aug 13, 2026 | Aug 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 3 | Initial insider ownership | Jul 8, 2026 | Jul 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2026 | Jul 5, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 3 | Initial insider ownership | Jun 17, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 29, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K | Current report | May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Dec 31, 2025 |
| 424B3 | Prospectus | Apr 27, 2026 | — |
| EFFECT | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 23, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2026 | — |
| S-3 | Shelf registration | Apr 21, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 20, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2026 | — |
| 4 | Insider transaction | Jan 5, 2026 | Jan 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 5, 2026 | — |
| EFFECT | Filing | Dec 22, 2025 | — |
| 424B3 | Prospectus | Dec 22, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 18, 2025 | — |
| 4 | Insider transaction | Dec 18, 2025 | Dec 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 18, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| S-3 | Shelf registration | Dec 15, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 9, 2025 | Dec 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 9, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 8, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 12, 2025 | Nov 12, 2025 |
| DEF 14A | Proxy statement | Nov 7, 2025 | Dec 11, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 28, 2025 | Dec 11, 2025 |
| PREM14A | Filing | Oct 27, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Oct 3, 2025 | Oct 2, 2025 |
| 8-K |
Current report
Other events
|
Sep 16, 2025 | Sep 11, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | Current report | Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 10, 2025 | Jul 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 9, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Feb 20, 2025 |
| ARS | Annual report to shareholders | May 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 22, 2025 | — |
| DEF 14A | Proxy statement | May 22, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K | Current report | May 2, 2025 | May 1, 2025 |
| PRE 14A | Preliminary proxy statement | May 2, 2025 | Apr 24, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 3, 2025 |
| 3 | Initial insider ownership | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Listing notice
|
Feb 13, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | Current report | Nov 12, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 3 | Initial insider ownership | Sep 11, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2024 | Sep 8, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K | Current report | Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 1, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Jun 28, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| S-8 | Employee stock plan registration | May 14, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Apr 24, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Apr 24, 2024 |
| 4 | Insider transaction | Mar 20, 2024 | Mar 18, 2024 |
| 10-K | Annual report | Mar 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2024 | Mar 8, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4/A | Filing | Feb 14, 2024 | Oct 8, 2019 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 29, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 4, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Dec 4, 2023 |
| EFFECT | Filing | Nov 15, 2023 | — |
| 424B5 | Prospectus supplement | Nov 15, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2023 | — |
| S-3 | Shelf registration | Nov 3, 2023 | — |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 18, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Other events
|
Oct 2, 2023 | Oct 2, 2023 |
| 10-Q | Quarterly report | Aug 4, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2023 | Aug 4, 2023 |
| SC 13G | Ownership over 5% (passive) | Jul 31, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| S-8 | Employee stock plan registration | May 5, 2023 | — |
| 10-Q | Quarterly report | May 5, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 5, 2023 | May 5, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Other events
|
Apr 27, 2023 | Apr 27, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 8, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| 10-K | Annual report | Mar 13, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 23, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 3, 2023 | — |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 4 | Insider transaction | Sep 14, 2022 | Sep 12, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Other events
|
May 11, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OVID (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1636651
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.